Teva

By Dave Muoio September 20, 2017
BioSensics, a Cambridge, Massachusetts-based developer of wearable health sensors, has received more than $2.5 million in NIH grant funding for its Huntington’s disease (HD) monitoring device. The device, called HDWear, provides real-time quantitative motor symptom scores that can assist with managing the hereditary neurological disease. These measures usually require in-clinic assessments such...
By Heather Mack October 26, 2016
Global pharmaceutical company Teva has joined forces with IBM in a three-year research collaboration that integrates with the Watson Health Cloud. The project builds on an existing alliance between the two companies and will focus on two key areas in healthcare: developing a systematic approach to discovering new uses for existing drugs and improving chronic disease management. The joint work in...
By Jonah Comstock September 27, 2015
Teva Pharmaceuticals will acquire Cambridge, Massachusetts-based Gecko Health Innovations (previously known as GeckoCap), a smart inhaler company. The terms of the deal were not disclosed. Gecko's main product is CareTRx a platform for chronic respiratory disease management that combines a sensor device that connects to most inhalers, a data analytics platform, an accessible user interface, and...
By Jonah Comstock June 4, 2015
While Teladoc has been pulling in a lot of press lately with its IPO news, competitor American Well has been busy too, securing an eight-figure investment from Israeli pharmaceutical giant Teva, according to a recent report in Israeli publication Globes. According to Globes, the investment of "tens of millions of dollars" is part of a new push into digital health by Teva, which has also included...